Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13

The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]

Authors Tian D, Shi X, Zhao Y , Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R , Chen L 

Received 20 February 2020

Accepted for publication 20 February 2020

Published 18 March 2020 Volume 2020:13 Pages 775—776

DOI https://doi.org/10.2147/DMSO.S250600




Tian D, Shi X, Zhao Y, et al. Diabet Metab Syndr Obes. 2019;12:1583– 1596.

The authors of this paper have advised that Figures 5 and 6 are incorrect. The authors provided only one actin control for each treatment. However, their different target proteins had their own matched actin from the same experiment. This does not change the conclusion of the paper. The authors apologize for this error.

Read the original article


Creative Commons License © 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.